Structure-directed linker optimization of novel HEPTs as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Qingqing Hao; Xiaomei Chen; Christophe Pannecouque; De Clercq Erik; Shuai Wang; Fen‐Er Chen

doi:10.1016/j.bioorg.2023.106413

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2005

Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Juliana Ruiz‐Caro, Aravind Basavapathruni, Joseph T. Kim, Christopher M. Bailey, Ligong Wang, Karen S. Anderson, Andrew D. Hamilton, William L. Jorgensen

Bioorganic & Medicinal Chemistry Letters

Article2006

Optimization of Diarylamines as Non‐Nucleoside Inhibitors of HIV‐1 Reverse Transcriptase.

Juliana Ruiz‐Caro, Aravind Basavapathruni, Joseph T. Kim, Christopher M. Bailey, Ligong Wang, Karen S. Anderson, Andrew D. Hamilton, William L. Jorgensen

ChemInform

Article2017

Designing Novel Hydrazinecarbothioamides as Potential HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Hong Yin, Zheng-Yong Wan, Ge Meng, Fen‐Er Chen, De Clercq Erik, and Christophe Pannecouque

Article2010

Lead Optimization of Diarylpyrimidines as Non‐nucleoside Inhibitors of HIV‐1 Reverse Transcriptase

Zhao‐Sen Zeng, Yonghong Liang, Xiaoqing Feng, Fen‐Er Chen, Christophe Pannecouque, Jan Balzarini, De Clercq Erik

Article2022

Linker optimization of HEPT derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors: From S=O to CHOR

Qingqing Hao, Ling Xu, Christophe Pannecouque, De Clercq Erik, Fen‐Er Chen